KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Astrazeneca (AZN) over the last 15 years, with Q4 2025 value amounting to $302.0 million.

  • Astrazeneca's Long-Term Investments rose 1268.66% to $302.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $302.0 million, marking a year-over-year increase of 1268.66%. This contributed to the annual value of $302.0 million for FY2025, which is 1268.66% up from last year.
  • Astrazeneca's Long-Term Investments amounted to $302.0 million in Q4 2025, which was up 1268.66% from $296.0 million recorded in Q3 2025.
  • Astrazeneca's Long-Term Investments' 5-year high stood at $1.5 billion during Q4 2023, with a 5-year trough of -$11.0 million in Q3 2023.
  • In the last 5 years, Astrazeneca's Long-Term Investments had a median value of $82.5 million in 2021 and averaged $248.4 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first tumbled by 12075.47% in 2023, then soared by 273636.36% in 2024.
  • Astrazeneca's Long-Term Investments (Quarter) stood at $69.0 million in 2021, then skyrocketed by 1444.93% to $1.1 billion in 2022, then soared by 43.53% to $1.5 billion in 2023, then tumbled by 82.48% to $268.0 million in 2024, then rose by 12.69% to $302.0 million in 2025.
  • Its Long-Term Investments stands at $302.0 million for Q4 2025, versus $296.0 million for Q3 2025 and $276.0 million for Q2 2025.